Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Altamira Therapeutics Ltd
(NQ:
CYTO
)
1.500
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.500
Bid (Size)
1.440 (3)
Ask (Size)
1.500 (10)
Prev. Close
1.500
Today's Range
1.500 - 1.500
52wk Range
0.0940 - 5.790
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
April 10, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Earnings Scheduled For April 10, 2024
April 10, 2024
Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion.
Via
Benzinga
Performance
YTD
-56.65%
-56.65%
1 Month
-10.71%
-10.71%
3 Month
-37.50%
-37.50%
6 Month
+848.17%
+848.17%
1 Year
+32.74%
+32.74%
More News
Read More
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
April 04, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Nasdaq Turns Higher; Akanda Shares Plunge
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CYTO Stock Earnings: Altamira Therapeutics Reported Results for H1 2023
December 14, 2023
Via
InvestorPlace
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
Via
Benzinga
Crude Oil Moves Higher; US New Home Sales Fall In February
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Altamira Therapeutics Stock Is Racing Higher
March 25, 2024
Via
Benzinga
US Stocks Down; Chicago Fed National Activity Index Rises In February
March 25, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
March 25, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
February 07, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
January 24, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 11, 2024
Via
InvestorPlace
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
January 08, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 29, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Via
InvestorPlace
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 11, 2023
Via
Benzinga
Why Altamira Therapeutics (CYTO) Stock Is Down 50% Today
December 11, 2023
Via
Benzinga
US Stocks Mixed; Cigna Shares Spike Higher
December 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Altamira Therapeutics Provides Investor and Business Update
December 11, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.